Chiltern inks a deal with Karolinska Development

CRO Chiltern has hooked up with Karolinska Development, signing on to run clinical trials for the group's many projects. Karolinska works to select and develop promising assets, then either sells or outlicenses them at a profit. Chiltern was chosen after an extensive CRO selection process, according to the company, and will lend its more than 30 years of trial experience. More